The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-30

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare between platelet-rich fibrin and platelet-rich plasma in female pattern hair loss . The main question\[s\] it aims to answer are:

* efficacy between platelet-rich fibrin and platelet-rich plasma
* safety between platelet-rich fibrin and platelet-rich plasma Participants will be divided into 2 side of treatment with composed of

1. Platelet rich plasma
2. Platelet rich fibrin

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia

NCT02074943

Androgenetic Alopecia

UNKNOWN NA

Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia

NCT06558565

Androgenetic Alopecia

NOT_YET_RECRUITING NA

Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women

NCT03488108

Alopecia

COMPLETED PHASE1/PHASE2

Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation

NCT07287579

Androgenic Alopecia

NOT_YET_RECRUITING NA

The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia

NCT03048461

Androgenetic Alopecia

WITHDRAWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subject was treated both platelet-rich fibrin and platelet-rich plasma for 3 times which 1 month interval then will be followed up at 4 months and 6 months after last treatment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Pattern Hair Loss Platelet-Rich Plasma Platelet-rich Fibrin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All subject were injected with PRP and PRF at baseline, 4 weeks and 8 weeks with split-head of sides of injection.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PRF and PRP

All patients were treated with both platelet rich fibrin and platelet rich plasma but each side of head (left or right) was split with

* one side of head was injected with platelet rich plasma at week 0,4 and 8 (total 3 times)
* another side of head was injected with platelet rich fibrin at week 0,4 and 8 (total 3 times)

Group Type EXPERIMENTAL

Platelet rich plasma

Intervention Type DEVICE

Subjects were treated by Platelet rich plasma in each side of head (Left or right)

Platelet rich fibrin

Intervention Type DEVICE

Subjects were treated by Platelet rich fibrin in each side of head (Left or right)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Platelet rich plasma

Subjects were treated by Platelet rich plasma in each side of head (Left or right)

Intervention Type DEVICE

Platelet rich fibrin

Subjects were treated by Platelet rich fibrin in each side of head (Left or right)

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PRP PRF

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 20-55 years
* Female
* Subject who was diagnosed with Female pattern hair loss in Ludwig Classification 2 (part width 2-4 centimeters) by Dermatologist

Exclusion Criteria

* Pregnancy or Lactation subjects
* Subject with history of platelet dysfunction, low platelet, anemia, cirrhosis, cancer, or immunocompromised host
* Subject who are active smoking and alcoholism
* Subject who has dermatitis, scar or infection at intervention area
* Subject who has history of allergy to anesthesia drug
* Subject who taking NSAIDs, Hormonal drug, anticoagulants drug
* Subject who has psychiatric condition diagnosed by psychiatrist
* Subject who are not allowed to take a photo

Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No